1. Zeng, Qiang, Tao, Junfeng, Qin, Lilu, Xu, Mingxian, Zeng, Linshan. 2024. Comprehensive prognostic gene identification and functional characterization of GRAMD1A in Wilms tumor: development of risk prediction models and therapeutic implications. In Frontiers in oncology, 14, 1501718. doi:10.3389/fonc.2024.1501718. https://pubmed.ncbi.nlm.nih.gov/39659787/
2. Liu, Yifu, Fu, Shengqiang, Zhang, Zhicheng, Sun, Ting, Ma, Ming. 2022. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment. In Disease markers, 2022, 5939021. doi:10.1155/2022/5939021. https://pubmed.ncbi.nlm.nih.gov/35860689/
3. Fu, Binsheng, Meng, Wei, Zhao, Hui, Li, Heping, Zhang, Tong. 2016. GRAM domain-containing protein 1A (GRAMD1A) promotes the expansion of hepatocellular carcinoma stem cell and hepatocellular carcinoma growth through STAT5. In Scientific reports, 6, 31963. doi:10.1038/srep31963. https://pubmed.ncbi.nlm.nih.gov/27585821/
4. Saberi, Fatemeh, Dehghan, Zeinab, Noori, Effat, Zali, Hakimeh. 2023. Identification of Renal Transplantation Rejection Biomarkers in Blood Using the Systems Biology Approach. In Iranian biomedical journal, 27, 375-87. doi:10.52547/ibj.3871. https://pubmed.ncbi.nlm.nih.gov/38224029/
5. Xiao, Xu, Kim, Youngjae, Romartinez-Alonso, Beatriz, Jung, Michael E, Tontonoz, Peter. . Selective Aster inhibitors distinguish vesicular and nonvesicular sterol transport mechanisms. In Proceedings of the National Academy of Sciences of the United States of America, 118, . doi:10.1073/pnas.2024149118. https://pubmed.ncbi.nlm.nih.gov/33376205/
6. Quan, Yongjun, Ping, Hao, Wang, Mingdong, Zhang, Xiaodong. 2023. RNA-Sequencing Analysis Indicates That N-Cadherin Promotes Prostate Cancer Progression by the Epigenetic Modification of Key Genes. In DNA and cell biology, 42, 563-577. doi:10.1089/dna.2023.0089. https://pubmed.ncbi.nlm.nih.gov/37540080/
智鼠故事 
